Terms: = Gastric cancer AND SRC, c-SRC, 6714, ENSG00000197122, P12931, ASV, p60-Src, SRC1, c-src
430 results:
1. The emerging roles of CEACAM6 in human cancer (Review).
Wu G; Wang D; Xiong F; Wang Q; Liu W; Chen J; Chen Y
Int J Oncol; 2024 Mar; 64(3):. PubMed ID: 38240103
[TBL] [Abstract] [Full Text] [Related]
2. CSK may be a potential prognostic biomarker reflecting the immune status of gastric cancer.
Yan X; Huan J
Eur Rev Med Pharmacol Sci; 2024 Jan; 28(1):221-230. PubMed ID: 38235873
[TBL] [Abstract] [Full Text] [Related]
3. PHB2 promotes SHIP2 ubiquitination via the E3 ligase NEDD4 to regulate AKT signaling in gastric cancer.
Xu L; Xiang W; Yang J; Gao J; Wang X; Meng L; Ye K; Zhao XH; Zhang XD; Jin L; Ye Y
J Exp Clin Cancer Res; 2024 Jan; 43(1):17. PubMed ID: 38200519
[TBL] [Abstract] [Full Text] [Related]
4. Characterization of gastric cancer-stimulated signaling pathways and function of CTGF in cancer-associated fibroblasts.
Choi KM; Kim B; Lee SM; Han J; Bae HS; Han SB; Lee D; Ham IH; Hur H; Kim E; Kim JY
Cell Commun Signal; 2024 Jan; 22(1):8. PubMed ID: 38167009
[TBL] [Abstract] [Full Text] [Related]
5. M-CSF secreted by gastric cancer cells exacerbates the progression of gastric cancer by increasing the expression of SHP2 in tumor-associated macrophages.
Zhang S; Ren D; Hou H; Yao L; Yuan H
Aging (Albany NY); 2023 Dec; 15(24):15525-15534. PubMed ID: 38159254
[TBL] [Abstract] [Full Text] [Related]
6. LncRNA-CCAT5-mediated crosstalk between Wnt/β-Catenin and STAT3 signaling suggests novel therapeutic approaches for metastatic gastric cancer with high Wnt activity.
Liu C; Shen A; Song J; Cheng L; Zhang M; Wang Y; Liu X
Cancer Commun (Lond); 2024 Jan; 44(1):76-100. PubMed ID: 38010289
[TBL] [Abstract] [Full Text] [Related]
7. Ropivacaine inhibits the proliferation and metastasis of gastric cancer cells via the SNX10/src/STAT3 pathway.
Deng RR; Yuan YP
Chem Biol Drug Des; 2024 Jan; 103(1):e14405. PubMed ID: 37989501
[TBL] [Abstract] [Full Text] [Related]
8. Total Versus Subtotal Gastrectomy for Distal gastric Poorly Cohesive Carcinoma.
Boubaddi M; Teixeira Farinha H; Lambert C; Pereira B; Piessen G; Gualtierotti M; Voron T; Mantziari S; Pezet D; Gronnier C;
Ann Surg Oncol; 2024 Feb; 31(2):744-752. PubMed ID: 37971616
[TBL] [Abstract] [Full Text] [Related]
9. VPS35 promotes gastric cancer progression through integrin/FAK/src signalling-mediated IL-6/STAT3 pathway activation in a YAP-dependent manner.
Zhou Q; Qi F; Zhou C; Ji J; Jiang J; Wang C; Zhao Q; Jin Y; Wu J; Cai Q; Tian H; Zhang J
Oncogene; 2024 Jan; 43(2):106-122. PubMed ID: 37950040
[TBL] [Abstract] [Full Text] [Related]
10. Pathway-driven analysis of synthetic lethal interactions in cancer using perturbation screens.
Karimpour M; Totonchi M; Behmanesh M; Montazeri H
Life Sci Alliance; 2024 Jan; 7(1):. PubMed ID: 37863651
[TBL] [Abstract] [Full Text] [Related]
11. FGF2 drives osteosarcoma metastasis through activating FGFR1-4 receptor pathway-mediated ICAM-1 expression.
Huang YC; Chen WC; Yu CL; Chang TK; I-Chin Wei A; Chang TM; Liu JF; Wang SW
Biochem Pharmacol; 2023 Dec; 218():115853. PubMed ID: 37832794
[TBL] [Abstract] [Full Text] [Related]
12. Exploring the mechanism of ellagic acid against gastric cancer based on bioinformatics analysis and network pharmacology.
Liu Z; Huang H; Yu Y; Li L; Shi X; Wang F
J Cell Mol Med; 2023 Dec; 27(23):3878-3896. PubMed ID: 37794689
[TBL] [Abstract] [Full Text] [Related]
13. A new triazolyl-indolo-quinoxaline induces apoptosis in gastric cancer cells by abrogating the STAT3/5 pathway through upregulation of PTPεC.
Suresh RN; Jung YY; Mohan CD; Gowda SV; Harsha KB; Mantelingu K; Sethi G; Ahn KS; Rangappa KS
Drug Dev Res; 2023 Dec; 84(8):1724-1738. PubMed ID: 37756467
[TBL] [Abstract] [Full Text] [Related]
14. The percentages of signet-ring cells (srcs) affects the prognosis after radical gastrectomy for advanced gastric cancer.
Ma Y; Wang Y; Hu C; Zi M; Chen J; Cao M; Yuan L; Yang L; Du Y
Langenbecks Arch Surg; 2023 Sep; 408(1):376. PubMed ID: 37743407
[TBL] [Abstract] [Full Text] [Related]
15. CAP2 promotes gastric cancer metastasis by mediating the interaction between tumor cells and tumor-associated macrophages.
Zhang G; Gao Z; Guo X; Ma R; Wang X; Zhou P; Li C; Tang Z; Zhao R; Gao P
J Clin Invest; 2023 Nov; 133(21):. PubMed ID: 37707957
[TBL] [Abstract] [Full Text] [Related]
16. Early Immune Changes Support Signet Ring Cell Dormancy in CDH1-Driven Hereditary Diffuse gastric Carcinogenesis.
Green BL; Gamble LA; Diggs LP; Nousome D; Patterson JC; Joughin BA; Gasmi B; Lux SC; Samaranayake SG; Miettinen M; Quezado M; Hernandez JM; Yaffe MB; Davis JL
Mol Cancer Res; 2023 Dec; 21(12):1356-1365. PubMed ID: 37707375
[TBL] [Abstract] [Full Text] [Related]
17. The potential effect and mechanism of Saikosaponin A against gastric cancer.
Wang C; Zhang R; Chen X; Yuan M; Wu J; Sun Q; Miao C; Jing Y
BMC Complement Med Ther; 2023 Aug; 23(1):295. PubMed ID: 37608281
[TBL] [Abstract] [Full Text] [Related]
18. Clinical significance of CD166 and HER-2 in different types of gastric cancer.
Moradi L; Tajik F; Saeednejad Zanjani L; Panahi M; Gheytanchi E; Biabanaki ZS; Kazemi-Sefat GE; Hashemi F; Dehghan Manshadi M; Madjd Z
Clin Transl Oncol; 2024 Mar; 26(3):664-681. PubMed ID: 37537510
[TBL] [Abstract] [Full Text] [Related]
19. SKAP1 Is a Novel Biomarker and Therapeutic Target for gastric cancer: Evidence from Expression, Functional, and Bioinformatic Analyses.
Zhu L; Yu Q; Li Y; Zhang M; Peng Z; Wang S; Quan Z; Gao D
Int J Mol Sci; 2023 Jul; 24(14):. PubMed ID: 37511629
[TBL] [Abstract] [Full Text] [Related]
20. Clinical implications and chemo-sensitivity of adjuvant chemotherapy in patients with poorly cohesive cells-gastric cancer.
Baek JH; Kang BW; Kang H; Cho M; Kwon OK; Park JY; Park KB; Seo AN; Kim JG
Cancer Chemother Pharmacol; 2023 Oct; 92(4):279-290. PubMed ID: 37480406
[TBL] [Abstract] [Full Text] [Related]
[Next]
